186 related articles for article (PubMed ID: 23890695)
1. Cyclotron Production of (99m)Tc using (100)Mo2C targets.
Richards VN; Mebrahtu E; Lapi SE
Nucl Med Biol; 2013 Oct; 40(7):939-45. PubMed ID: 23890695
[TBL] [Abstract][Full Text] [Related]
2. Cyclotron production of
Gumiela M
Nucl Med Biol; 2018 Mar; 58():33-41. PubMed ID: 29331921
[TBL] [Abstract][Full Text] [Related]
3. Assessment of radionuclidic impurities in cyclotron produced (99m)Tc.
Lebeda O; van Lier EJ; Štursa J; Ráliš J; Zyuzin A
Nucl Med Biol; 2012 Nov; 39(8):1286-91. PubMed ID: 22796396
[TBL] [Abstract][Full Text] [Related]
4. Implementation of Multi-Curie Production of (99m)Tc by Conventional Medical Cyclotrons.
Bénard F; Buckley KR; Ruth TJ; Zeisler SK; Klug J; Hanemaayer V; Vuckovic M; Hou X; Celler A; Appiah JP; Valliant J; Kovacs MS; Schaffer P
J Nucl Med; 2014 Jun; 55(6):1017-22. PubMed ID: 24722529
[TBL] [Abstract][Full Text] [Related]
5. Cyclotron production of (99m)Tc: experimental measurement of the (100)Mo(p,x)(99)Mo, (99m)Tc and (99g)Tc excitation functions from 8 to 18 MeV.
Gagnon K; Bénard F; Kovacs M; Ruth TJ; Schaffer P; Wilson JS; McQuarrie SA
Nucl Med Biol; 2011 Aug; 38(6):907-16. PubMed ID: 21843787
[TBL] [Abstract][Full Text] [Related]
6. Analysis of radioactive waste generated during the cyclotron production of
Stothers LA; Hou X; Vuckovic M; Buckley K; Bénard F; Schaffer P; Celler A
Phys Med Biol; 2019 Feb; 64(5):055008. PubMed ID: 30669132
[TBL] [Abstract][Full Text] [Related]
7. Graphical user interface for yield and dose estimations for cyclotron-produced technetium.
Hou X; Vuckovic M; Buckley K; Bénard F; Schaffer P; Ruth T; Celler A
Phys Med Biol; 2014 Jul; 59(13):3337-52. PubMed ID: 24874744
[TBL] [Abstract][Full Text] [Related]
8. Theoretical modeling of yields for proton-induced reactions on natural and enriched molybdenum targets.
Celler A; Hou X; Bénard F; Ruth T
Phys Med Biol; 2011 Sep; 56(17):5469-84. PubMed ID: 21813960
[TBL] [Abstract][Full Text] [Related]
9. Radioisotopic purity and imaging properties of cyclotron-produced
Uzunov NM; Melendez-Alafort L; Bello M; Cicoria G; Zagni F; De Nardo L; Selva A; Mou L; Rossi-Alvarez C; Pupillo G; Di Domenico G; Uccelli L; Boschi A; Groppi F; Salvini A; Taibi A; Duatti A; Martini P; Pasquali M; Loriggiola M; Marengo M; Strada L; Manenti S; Rosato A; Esposito J
Phys Med Biol; 2018 Sep; 63(18):185021. PubMed ID: 30229740
[TBL] [Abstract][Full Text] [Related]
10. Diversification of 99Mo/99mTc separation: non–fission reactor production of 99Mo as a strategy for enhancing 99mTc availability.
Pillai MR; Dash A; Knapp FF
J Nucl Med; 2015 Jan; 56(1):159-61. PubMed ID: 25537991
[TBL] [Abstract][Full Text] [Related]
11. 99Mo/(99m)Tc separation: an assessment of technology options.
Dash A; Knapp FF; Pillai MR
Nucl Med Biol; 2013 Feb; 40(2):167-76. PubMed ID: 23142410
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of relationships between irradiation parameters and the reproducibility of cyclotron-produced (99m)Tc yields.
Tanguay J; Hou X; Buckley K; Schaffer P; Bénard F; Ruth TJ; Celler A
Phys Med Biol; 2015 May; 60(10):3883-903. PubMed ID: 25909462
[TBL] [Abstract][Full Text] [Related]
13. An automated module for the separation and purification of cyclotron-produced 99mTcO4-.
Morley TJ; Dodd M; Gagnon K; Hanemaayer V; Wilson J; McQuarrie SA; English W; Ruth TJ; Bénard F; Schaffer P
Nucl Med Biol; 2012 May; 39(4):551-9. PubMed ID: 22226026
[TBL] [Abstract][Full Text] [Related]
14. Internal radiation dose assessment of radiopharmaceuticals prepared with cyclotron-produced
Meléndez-Alafort L; Ferro-Flores G; De Nardo L; Bello M; Paiusco M; Negri A; Zorz A; Uzunov N; Esposito J; Rosato A
Med Phys; 2019 Mar; 46(3):1437-1446. PubMed ID: 30661241
[TBL] [Abstract][Full Text] [Related]
15. Sustained availability of 99mTc: possible paths forward.
Pillai MR; Dash A; Knapp FF
J Nucl Med; 2013 Feb; 54(2):313-23. PubMed ID: 23255729
[TBL] [Abstract][Full Text] [Related]
16. Feasibility studies towards future self-sufficient supply of the (99)Mo-(99m)Tc isotopes with Japanese accelerators.
Nakai K; Takahashi N; Hatazawa J; Shinohara A; Hayashi Y; Ikeda H; Kanai Y; Watabe T; Fukuda M; Hatanaka K
Proc Jpn Acad Ser B Phys Biol Sci; 2014; 90(10):413-21. PubMed ID: 25504230
[TBL] [Abstract][Full Text] [Related]
17. A simple and rapid technique for recovery of (99m)Tc from low specific activity (n,gamma)(99)Mo based on solvent extraction and column chromatography.
Chattopadhyay S; Das SS; Barua L
Appl Radiat Isot; 2010 Jan; 68(1):1-4. PubMed ID: 19720541
[TBL] [Abstract][Full Text] [Related]
18. In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals.
Martini P; Boschi A; Cicoria G; Zagni F; Corazza A; Uccelli L; Pasquali M; Pupillo G; Marengo M; Loriggiola M; Skliarova H; Mou L; Cisternino S; Carturan S; Melendez-Alafort L; Uzunov NM; Bello M; Alvarez CR; Esposito J; Duatti A
Appl Radiat Isot; 2018 Sep; 139():325-331. PubMed ID: 29936404
[TBL] [Abstract][Full Text] [Related]
19. Preparation of clinical-scale 99Mo/99mTc column generator using neutron activated low specific activity 99Mo and nanocrystalline γ-Al2O3 as column matrix.
Chakravarty R; Ram R; Dash A; Pillai MR
Nucl Med Biol; 2012 Oct; 39(7):916-22. PubMed ID: 22632898
[TBL] [Abstract][Full Text] [Related]
20. Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons.
Boschi A; Martini P; Pasquali M; Uccelli L
Drug Dev Ind Pharm; 2017 Sep; 43(9):1402-1412. PubMed ID: 28443689
[No Abstract] [Full Text] [Related]
[Next] [New Search]
